Vipanan Reinforces Its Leadership in India’s Water Treatment Diagnostics Industry

Vipanan Analytical Technologies LLP (“Vipanan”) reaffirms its position as India’s foremost independent laboratory specializing in membrane autopsy and advanced water-treatment diagnostics. Founded in 2003, Vipanan offers impartial, science-backed services to clients across industries that rely on membrane-based systems such as RO (reverse osmosis), NF (nanofiltration), UF (ultrafiltration), and MBR (membrane bioreactor) technologies.

Unmatched Expertise & Certifications

Vipanan operates under the highest standards of laboratory quality and independence, being ISO/IEC 17025:2005 (NABL accredited) and ISO 9001:2015 certified. These credentials underscore the lab’s commitment to rigorous, reproducible diagnostics.

Comprehensive Service Offerings

Vipanan’s services include:

Membrane Autopsy (RO/NF/UF/MBR): Detailed forensic evaluation of membrane elements to identify root causes of performance decline—such as fouling, scaling, chemical damage, or mechanical degradation.

Antiscalant Efficacy Testing & Chemical Compatibility Studies: Evaluation of antiscalants, cleansers, and biocides under site-specific conditions to optimise performance and longevity of membrane systems.

Feasibility Studies, Pilot Testing & Contract R&D: Tailored investigations to assist clients with system design, operational optimisation and treatment strategy decisions.

Challenge Water & Value-Added Diagnostics: Addressing high-TDS, difficult-to-treat waters and providing advanced diagnostics beyond standard analyses.

Why Vipanan is Trusted

Complete Independence: Vipanan is a fully third-party lab with no ties to membrane or chemical suppliers—ensuring objective results and honest recommendations.

Proven Track Record: With over two decades of experience, Vipanan has supported hundreds of clients, providing thousands of diagnostic reports across sectors.

Actionable Insights: Beyond identifying problems, Vipanan delivers practical recommendations—whether adjusting pretreatment, revising CIP protocols or redesigning systems—to help clients extend membrane life and reduce operational risk.